Amneal Pharmaceuticals Interest Expense 2011-2026 | AMRX

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Amneal Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
16.5 M	11.8 M	8.24 M	18.5 M	15.3 M	2.59 M	1.46 M	1.18 M	-47 K	-669 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
18.5 M	-669 K	7.49 M

Quarterly Interest Expense Amneal Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.24 M	1.6 M	518 K	1.18 M	4.36 M	4.07 M	1.83 M	417 K	4.36 M	-	5.71 M	6.94 M	2.12 M	-	3.87 M	4.03 M	794 K	-	898 K	571 K	633 K	-	446 K	149 K	1.11 M	-	-1.01 M	791 K	948 K	-	-93 K	-78 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
6.94 M	-1.01 M	1.82 M

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Alector ALEC	13.2 M	$ 2.08	-14.4 %	$ 214 M	USA
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
Altimmune ALT	48 K	$ 4.2	-2.67 %	$ 298 M	USA
Apellis Pharmaceuticals APLS	-133 K	$ 20.24	-3.44 %	$ 2.55 B	USA
Aprea Therapeutics APRE	1.19 M	$ 0.88	-3.72 %	$ 3.18 M	USA
Aptevo Therapeutics APVO	472 K	$ 7.2	-1.64 %	$ 1.99 M	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
Aquestive Therapeutics AQST	6.55 M	$ 4.1	2.37 %	$ 356 M	USA
AgeX Therapeutics AGE	4.9 M	-	-10.17 %	$ 12.2 K	USA
Arcturus Therapeutics Holdings ARCT	15.2 M	$ 8.35	1.46 %	$ 225 M	Israel
Ardelyx ARDX	4.5 M	$ 6.37	-2.75 %	$ 1.54 B	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Armata Pharmaceuticals ARMP	-28.2 M	$ 10.91	1.58 %	$ 394 M	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Arcutis Biotherapeutics ARQT	443 K	$ 25.33	-6.1 %	$ 3.22 B	USA
Artelo Biosciences ARTL	194 K	$ 1.15	-3.36 %	$ 2.32 M	USA
Arvinas ARVN	-400 K	$ 12.97	-2.3 %	$ 920 M	USA
Arrowhead Pharmaceuticals ARWR	5.26 M	$ 61.74	-2.42 %	$ 8.26 B	USA
Ascendis Pharma A/S ASND	80.6 M	$ 231.56	-0.83 %	$ 5 B	Danmark
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.39	-1.63 %	$ 8.16 B	Australia
Actinium Pharmaceuticals ATNM	1.09 M	$ 1.17	-0.85 %	$ 35.2 M	USA
Atossa Therapeutics ATOS	-70 K	$ 4.39	-0.9 %	$ 553 M	USA
Atara Biotherapeutics ATRA	4.62 M	$ 5.01	-7.47 %	$ 37.5 M	USA
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
Autolus Therapeutics plc AUTL	9.29 M	$ 1.68	-1.75 %	$ 429 M	Britain
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Anavex Life Sciences Corp. AVXL	4.68 M	$ 4.54	2.44 %	$ 387 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Axon Enterprise AXON	286 M	$ 570.5	5.18 %	$ 43.2 B	USA
Axsome Therapeutics AXSM	-15.9 M	$ 162.28	-0.98 %	$ 8.07 B	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Aytu BioScience AYTU	-512 K	$ 2.56	-0.58 %	$ 16.1 M	USA
Aileron Therapeutics ALRN	685 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA